Study design of a non-interventional registry study to establish long-term safety and pharmaco-economic data on fingolimod (Gilenya®) in multiple sclerosis patients (PANGAEA)

被引：0
|
作者：
van Lokven, T.
Kempcke, R.
Ziemssen, T.
Meergans, M.
机构：
[1] Novartis Pharma GmbH, Nurnberg, Germany
[2] Karl Gustav Carus Univ Hosp, Dresden, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P502
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [41] Young adult RRMS patients treated with fingolimod in daily clinical practice: interim results of the non-interventional study PANGAEA
    Ziemsseni, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    Ettle, B.
    Schulze-Topphoff, U.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 500 - 500
  • [42] The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary
    Biernacki, Tamas
    Sandi, Daniel
    Fuvesi, Judit
    Fricska-Nagy, Zsanett
    Kincses, Tamas Zsigmond
    Acs, Peter
    Rozsa, Csilla
    Dobos, Eniko
    Cseh, Botond
    Horvath, Laszlo
    Nagy, Zsuzsanna
    Csanyi, Attila
    Kovacs, Krisztina
    Csepany, Tunde
    Vecsei, Laszlo
    Bencsik, Krisztina
    PLOS ONE, 2022, 17 (04):
  • [43] Non-Interventional Post-Authorization Safety Study (PASS) on the Long-Term Safety of HYQVIA® (IGHY)
    Fielhauer, K.
    Nikolov, N.
    Hermann, C.
    Nagy, A.
    Schiff, R. I.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S294 - S294
  • [44] A RESTROSPECTIVE NON-INTERVENTIONAL STUDY AMONG PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS SWITCHING TO FINGOLIMOD OR TO OTHER DISEASE MODIFYING THERAPIES
    Medin, J.
    Haddad, P.
    Ricart, J.
    Lara, N.
    Pedros, M.
    Bizouard, G.
    Loefroth, E.
    VALUE IN HEALTH, 2016, 19 (07) : A427 - A427
  • [45] ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis
    Specker, C.
    Alberding, A.
    Aringer, M.
    Burmester, G-R
    Flacke, J-P
    Hofmann, M. W.
    Kaestner, P.
    Kellner, H.
    Moosig, F.
    Sieburg, M.
    Tony, H-P
    Fliedner, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (02) : 319 - 328
  • [46] 5 years safety of fingolimod in real world: First results from PANGAEA, a non-interventional study of RRMS patients treated with fingolimod, on safety and adherence after 5 years of fingolimod in daily clinical practice
    Ziemssen, Tjalf
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Cornelissen, Christian
    NEUROLOGY, 2017, 88
  • [47] Patients switching to fingolimod in daily clinical routine: 2 year interim results from the non-interventional study PANGAEA 2.0
    Schulze-Topphoff, U.
    Ettle, B.
    Cornelissen, C.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 932 - 932
  • [48] PANGAEA: the average German fingolimod patient. Demographics and baseline characteristics from a 5 year non-interventional study of RRMS patients treated with fingolimod
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 695 - 695
  • [49] PANGAEA: The average German fingolimod patient. Demographics and baseline characteristics from a 5 year non-interventional study of RRMS patients treated with fingolimod
    Ziemssen, T.
    Albrecht, H.
    Klotz, L.
    Schmidt, S.
    Schwarz, H-J
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 620 - 620
  • [50] LONG-TERM SAFETY OF ADALIMUMAB IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: INTERIM RESULTS OF A NON-INTERVENTIONAL REGISTRY, LEGACY
    Bossuyt, Peter
    Atreya, Raja
    Samso, Carlos Taxonera
    Hebuterne, Xavier
    Isaacs, Kim
    Higgins, Peter D.
    Lindsay, James O.
    Heap, Graham
    Arikan, Dilek
    Kuehnl, Vera
    Petersson, Joel H.
    Robinson, Anne M.
    Loftus, Edward V.
    GASTROENTEROLOGY, 2018, 154 (06) : S829 - S829
12345